We are live on ! Find out more
Sanders Capital

Sanders Capital Portfolio holdings

AUM $99.8B
1-Year Est. Return 47.9%
This Fund
S&P 500
This Quarter Est. Return
-1.39%
1 Year Est. Return
+47.9%
3 Year Est. Return
+147.14%
5 Year Est. Return
+192.43%
10 Year Est. Return
+815.46%
AUM
$47.3B
AUM Growth
-$545M
Cap. Flow
+$735M
Cap. Flow %
1.55%
Top 10 Hldgs %
63.85%
Holding
50
New
1
Increased
36
Reduced
5
Closed
6

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$1.05B
2
AZN icon
AstraZeneca
AZN
+$721M
3
UNH icon
UnitedHealth
UNH
+$174M
4
RTX icon
RTX Corp
RTX
+$144M
5
SLB icon
SLB Ltd
SLB
+$121M

Sector Composition

Rank Sector Weight
1 Technology 28%
2 Healthcare 24.3%
3 Communication Services 16.93%
4 Energy 6.99%
5 Consumer Staples 5.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZN icon
26
AstraZeneca
AZN
$246B
$715M 1.51%
+5,280,551
New +$721M
C icon
27
Citigroup
C
$228B
$473M 1%
11,496,482
+30,501
+0.3% +$1.34M
SLB icon
28
SLB Ltd
SLB
$79.7B
$470M 0.99%
8,056,492
+2,085,506
+35% +$121M
SPY icon
29
State Street SPDR S&P 500 ETF Trust
SPY
$807B
$180M 0.38%
421,736
+31,850
+8% +$14.2M
NVS icon
30
Novartis
NVS
$294B
$104M 0.22%
1,073,420
+710
+0.1% +$72.1K
BIDU icon
31
Baidu
BIDU
$35.9B
$84.1M 0.18%
626,033
+56,720
+10% +$7.95M
APTV icon
32
Aptiv
APTV
$10.3B
$83M 0.18%
842,154
+310
+0% +$32K
BAC icon
33
Bank of America
BAC
$448B
$83M 0.18%
3,029,754
+19,080
+0.6% +$564K
ABBV icon
34
AbbVie
ABBV
$442B
$82.8M 0.18%
555,458
+350
+0.1% +$51.4K
TFC icon
35
Truist Financial
TFC
$63.9B
$62.2M 0.13%
2,175,564
+2,180
+0.1% +$67K
NVDA icon
36
NVIDIA
NVDA
$5.27T
$19.7M 0.04%
454,000
UL icon
37
Unilever
UL
$134B
$6.79M 0.01%
122,116
+1,352
+1% +$78.1K
HSBC icon
38
HSBC
HSBC
$355B
$3.75M 0.01%
95,080
+21,380
+29% +$843K
SHG icon
39
Shinhan Financial Group
SHG
$34.3B
$3.66M 0.01%
138,144
LW icon
40
Lamb Weston
LW
$7.23B
$3.29M 0.01%
35,570
+200
+0.6% +$20.3K
ING icon
41
ING
ING
$101B
$3.08M 0.01%
233,902
+4,300
+2% +$60.6K
NWG icon
42
NatWest
NWG
$75.8B
$1.85M ﹤0.01%
316,505
+4,000
+1% +$24.2K
SMFG icon
43
Sumitomo Mitsui Financial
SMFG
$160B
$1.38M ﹤0.01%
140,363
+2,400
+2% +$22.2K
SYF icon
44
Synchrony
SYF
$25.5B
$1.06M ﹤0.01%
34,770
+700
+2% +$23.3K
DHI icon
45
D.R. Horton
DHI
$42.2B
-4,551,215
Closed -$554M
GM icon
46
General Motors
GM
$78.4B
-147,050
Closed -$5.67M
JNJ icon
47
Johnson & Johnson
JNJ
$626B
-3,803,314
Closed -$630M
LEA icon
48
Lear
LEA
$8.12B
-556,400
Closed -$79.9M
LEN icon
49
Lennar Class A
LEN
$21.1B
-2,220,272
Closed -$269M
MTH icon
50
Meritage Homes
MTH
$4.81B
-19,842
Closed -$1.41M

Similar funds

Sanders Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Sanders Capital held 50 positions worth $47.3B, down 1.1% from $47.9B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Sanders Capital's Q3 2023 filing shows 1 new, 36 increased, 5 reduced and 6 closed positions. Its largest new stake was AstraZeneca: 5,280,551 shares worth $715M. The largest sale was Johnson & Johnson, an estimated $630M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Communication Services.

  • Sanders Capital's largest Q3 2023 buy was AstraZeneca: 5,280,551 shares worth $715M.
  • Sanders Capital added most to Alibaba in Q3 2023, an estimated $1.05B increase.
  • Sanders Capital's biggest Q3 2023 reduction was Vanguard FTSE All-World ex-US ETF, cutting an estimated $33.9M.
  • Sanders Capital fully exited Johnson & Johnson in Q3 2023, selling an estimated $630M.
  • Sanders Capital's ten largest holdings make up 64% of its $47.3B portfolio in Q3 2023.
  • Sanders Capital opened 1 new position and closed 6 in Q3 2023.
  • Sanders Capital's portfolio value fell 1.1% quarter-over-quarter to $47.3B.

Based on Sanders Capital's 13F filing for Q3 2023, filed 9 Nov 2023.